Can a pill or patience replace surgery for retained tissue after abortion?
NCT ID NCT07534982
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at two ways to manage leftover tissue in the womb after a first-trimester medical abortion: giving a drug called misoprostol or simply waiting. About 150 women aged 18-45 with ultrasound-confirmed retained tissue will be randomly assigned to one of these approaches. The goal is to see which method works better at clearing the tissue and avoiding the need for a surgical procedure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
misoprostol
What this could lead to
If successful, this could show that a simple medication or watchful waiting is enough to avoid surgery for retained tissue after an abortion.
What could go wrong
This is a small, early-stage trial with only 150 participants. The results may not apply to everyone, and some women may still need surgery or face complications like infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETAINED PRODUCT OF CONCEPTION AFTER FIRST TRIMESTER MEDICAL ABORTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Meir Medical Center
RECRUITINGKfar Saba, 4861027, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••